Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 929-144-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 01 July 1998 - 15 July 1998
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
- Report date:
- 1998
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- 4-chloro-6-ethyl-5-fluoropyrimidine; dichloromethane
- EC Number:
- 929-144-0
- IUPAC Name:
- 4-chloro-6-ethyl-5-fluoropyrimidine; dichloromethane
- Test material form:
- liquid
- Details on test material:
- Clear yellow liquid
Storage conditions: Room temperature in the dark
Constituent 1
- Specific details on test material used for the study:
- Clear yellow liquid
Storage conditions: room temperature in the dark
Batch number: 5494/95/2
Test animals
- Species:
- rat
- Strain:
- other: Hsd:Sprague-Dawley(CD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals were in the weight range of 227 to 260 g and approximately eight to eleven weeks of age prior to dosing (Day 1). All the rats were acclimatised to the experimental environment for a minimum period of six days prior to the start of the study. The rats were allocated without conscious bias to cages within the treatment group. They were housed individually in metal cages. A standard laboratory rodent diet and drinking water were provided ad libitum. Thermostatic controls were set to maintain a temperature of 22 ± 3° C. Each animal was identified by cage number and ear punching.
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- The test substance was applied by spreading it evenly over the prepared skin. The treatment area (approximately 50 mm x 50 mm) was covered with porous gauze held in place with a non irritating dressing, and further covered by a waterproof dressing encircled firmly around the trunk of the animal.
Treatment in this manner was performed on Day 1 (day of dosing) of the study only. At the end of the 24 hours exposure period the dressings was carefully removed and the treated area of skin was washed with warm water (30° to 40°C) to remove any residual test substance. The treated
area was blotted dry with absorbent paper. - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- A group of ten rats (five males and five females)
- Control animals:
- no
- Details on study design:
- Dermal responses
Local dermal irritation at the treatment site was assessed daily using the following numerical scoring system:
Erythema and eschar formation:
No erythema 0
Slight erythema 1
Well defined 2
Moderate erythema 3
Severe erythema (beet redness) to slight eschar formation (injuries in depth) 4
Oedema formation:
No oedema
Slight 1
Well-defined oedema (edges of area well-defined by definite raising) 2
Moderate oedema (raised approximately 1 millimetre) 3
Severe oedema (raised more than 1 millimetre and extending beyond the
area of exposure) 4
Any other lesion not covered by this scoring system was described.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- discriminating dose
- Effect level:
- 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- no indication of skin irritation up to the relevant limit dose level
- Mortality:
- Cages of rats were checked at least twice daily for mortalities. All animals were killed on Day 15 by carbon dioxide asphyxiation.
- Clinical signs:
- other: Hyperactivity was first evident within eight minutes following removal of the dressings and accompanied on later intervals during the study by hunched posture, waddling/unsteady gait, lethargy, partially closed eyelids, pallid extremities, walking on toes
- Gross pathology:
- No abnormalities were recorded at the macroscopic examination on Day 15.
- Other findings:
- Dermal Responses: A well-defined dermal response (erythema/oedema Grades 1 to 3) was first evident in all rats following removal of the dressings with a similar response also apparent 48 hours after dosing. By Day 4 reactions had notably ameliorated in the majority of rats and dermal reactions had resolved in all instances by Day 9.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- There were no deaths in any animal throughout the study following a single dermal application of UK- 103,444 to a group of ten rats (five males and five females) at a dose level of 2000 mg/kg bodyweight.
- Executive summary:
The acute lethal dermal dose to rats of UK-103,444 was demonstrated to be greater than 2000 mg/kg bodyweight. On the basis of findings in this study and in accordance with EU hazard classification UK-103,444 will
not require labelling with the risk phrase GHS classification of acute tox. category 4, H-312: "Harmful in contact with skin"
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.